Study on Treating by Eating: Role of AGEs on Mucosal Barrier and Microbiome. (STEAMM)

August 7, 2024 updated by: JoaoSabino, Universitaire Ziekenhuizen KU Leuven

This is an exploratory study aimed at healthy volunteers to investigate the impact of differential cooking methods on global and gut inflammation, intestinal permeability, and the gut microbiota. The investigators hypothesize that a short dietary intervention of baking and grilling of food for 2 weeks as opposed to steaming and boiling of food for 2 weeks will result in measurable differences in blood, stool and urine samples that guide towards gut and overall health and disease. All food will be provided, together with detailed cooking instructions. Food logs including photographs will be used to check whether participants complied with the study.

The investigators aim to better understand the role of cooking methods in human health, so that this can be implemented in preventive strategies and dietary treatments for specific patient groups.

Study Overview

Status

Completed

Conditions

Detailed Description

This is a pilot project aimed at healthy volunteers to investigate the impact of differential cooking methods on systemic and intestinal inflammation, permeability, and the gut microbiota, using a randomised cross-over design. The investigators hypothesize that a short dietary intervention of baking and grilling of food for 2 weeks (high-Advanced Glycation End Products (AGEs) diet) as opposed to steaming and boiling of food for 2 weeks (low-AGEs diet) will result in measurable differences in inflammatory, cardiometabolic and microbial markers in blood and stool as well as changes in intestinal permeability through their effect on dietary AGEs. All food will be provided, together with detailed cooking instructions. Food logs including photographs will be used to assess and check adherence to the intervention.

The investigators aim to better understand the role of cooking methods and thermal treatments in human health, so that this can be implemented in preventive strategies and dietary treatments for specific patient groups.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium
        • University Hospital of Leuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Overall healthy
  • Adhering to an omnivorous diet
  • Body Mass Index (BMI) between 18.5 - 30 kg/m2
  • Able to provide consent.

Exclusion Criteria:

  • Participants with chronic illnesses including diabetes mellitus, cardiovascular disease, or cancer; eating disorders, irritable bowel syndrome; inflammatory bowel diseases, and previous bowel surgery (except for appendectomy).
  • Current smoking
  • Participants taking nonsteroidal anti-inflammatory drugs (NSAIDS), proton pump inhibitors, antacids, or laxatives one month before enrollment or antibiotics, prebiotics or probiotics six months before the start of the trial.
  • Pregnancy of lactation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HL
High-to-Low AGEs diet
Participants sequentially consumed a diet that was high in AGEs and low in AGEs just be altering their cooking method. The High AGEs diet was cooked for example by baking and grilling.
Participants sequentially consumed a diet that was high in AGEs and low in AGEs just be altering their cooking method. The low AGEs diet was cooked for example by steaming and boiling.
Experimental: LH
Low-to-High AGEs diet
Participants sequentially consumed a diet that was high in AGEs and low in AGEs just be altering their cooking method. The High AGEs diet was cooked for example by baking and grilling.
Participants sequentially consumed a diet that was high in AGEs and low in AGEs just be altering their cooking method. The low AGEs diet was cooked for example by steaming and boiling.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intestinal inflammation
Time Frame: 2 weeks
Measurement of faecal calprotectin through stool samples (in mg/kg)
2 weeks
Gut microbial metabolism
Time Frame: 2 weeks
Measurement of short chain fatty acids including acetic acid, propionic acid and butyric acid through stool samples (in mg/100g stool)
2 weeks
Gut microbial composition
Time Frame: 2 weeks
Measurement of the composition of the gut microbiota using 16s rRNA sequencing of stool samples.
2 weeks
Intestinal transcellular permeability
Time Frame: 2 weeks
Measurement of transcellular intestinal permeability using lipopolysaccharide binding protein in blood samples
2 weeks
Intestinal paracellular permeability
Time Frame: 2 weeks
Measurement of paracellular intestinal permeability using the lacultulose mannitol test using urine samples
2 weeks
Systemic inflammation
Time Frame: 2 weeks
serum inflammation through OLINK inflammatory panel (measurement of 92 proteins in blood)
2 weeks
Systemic inflammation
Time Frame: 2 weeks
Every serum CRP in blood samples (in mg/l)
2 weeks
Systemic cardiometabolic health
Time Frame: 2 weeks
serum cardiometabolic parameters through OLINK cardiometabolic panel (measurement of 92 proteins in blood)
2 weeks
Systemic lipid profile
Time Frame: 2 weeks
Total, LDL- and HDL-cholesterol values in blood samples (in mg/dl)
2 weeks
Weight changes
Time Frame: 2 weeks
weight (in kg)
2 weeks
Handgrip strength changes
Time Frame: 2 weeks
Handgrip strength (in kg)
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: João Sabino, MD, Leuven University Hospitals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Actual)

May 3, 2022

Study Completion (Actual)

July 30, 2022

Study Registration Dates

First Submitted

July 31, 2024

First Submitted That Met QC Criteria

August 7, 2024

First Posted (Actual)

August 9, 2024

Study Record Updates

Last Update Posted (Actual)

August 9, 2024

Last Update Submitted That Met QC Criteria

August 7, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

To be discussed upon request.

IPD Sharing Time Frame

Upon request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on High AGEs diet

Subscribe